Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome

Arthritis and Rheumatism

Volumn 56, Issue 12, 2007, Pages 4182-4188

  Todd, Ian ^a,d   Radford, Paul M ^a   Ziegler Heitbrock, Loems ^b,c   Ghaemmaghami, Amir M ^a   Powell, Richard J ^a   Tighe, Patrick J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; LIPOPOLYSACCHARIDE; PHORBOL MYRISTATE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

ADULT; AUTOIMMUNE DISEASES; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MUTATION; PERIODICITY; RECEPTORS, IGG; RECEPTORS, TUMOR NECROSIS FACTOR; SYNDROME;

EID: 37149044988     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23133     Document Type: Article

References (23)

1. McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFRSF1A, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133-44.
2. Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ, et al. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford) 2006;45:31-7.
3. Hull KM, Wong K, Wood GM, Chu WS, Kastner DL. Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis Rheum 2002;46:2189-94.
4. Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 2000;136:1487-94.
5. Ziegler-Heitbrock HW. Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol Today 1996;17:424-8.
6. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+ DR++ monocytes are a major source of TNF. J Immunol 2002;168:3536-42.
7. Horelt A, Belge KU, Steppich B, Prinz J, Ziegler-Heitbrock L. The CD14+CD16+ monocytes in erysipelas are expanded and show reduced cytokine production. Eur J Immunol 2002;32:1319-27.
8. Fernandez GC, Ramos MV, Gomez SA, Dran GI, Exeni R, Alduncin M, et al. Differential expression of function-related antigens on blood monocytes in children with haemolytic uremic syndrome. J Leukoc Biol 2005;78:853-61.
9. Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, et al. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002;46:2578-86.
10. strong monocytes in peripheral blood. Immunobiology 2000;202:2-10.
11. Hepburn AL, Mason JC, Davies KA. Expression of Fcγ and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) 2004;43:547-54.
12. Dayyani F, Belge KU, Frankenberger M, Mack M, Berki T, Ziegler-Heitbrock L. Mechanisms of glucocorticoid-induced depletion of human CD14+CD16+ monocytes. J Leukoc Biol 2003;74:33-9.
13. Steppich B, Dayyani F, Gruber R, Lorenz R, Mack M, Ziegler-Heitbrock HW. Selective mobilization of CD14+CD16+ monocytes by exercise. Am J Physiol Cell Physiol 2000;279:C578-86.
14. Siebert S, Amos N, Fielding CA, Wang EC, Aksentijevich I, Williams BD, et al. Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis Rheum 2005;52:1287-92.
15. D'Osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F, et al. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum 2006;54:998-1008.
16. Todd I, Radford PM, Draper-Morgan KA, McIntosh R, Bainbridge S, Dickinson P, et al. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology 2004;113:65-79.
17. Rebelo SL, Bainbridge SE, Amel-Kashipaz MR, Radford PM, Powell RJ, Todd I, et al. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum 2006;54:2674-87.
18. Yousaf N, Gould DJ, Aganna E, Hammond L, Mirakian RM, Turner MD, et al. Tumor necrosis factor receptor I from patients with tumor necrosis factor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-κB activation. Arthritis Rheum 2005;52:2906-16.
19. Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signalling by TNFR1 mutants in the TNFR1 associated periodic fever syndrome (TRAPS). Blood 2006;108:1320-7.
20. Todd I, Radford PM, Daffa N, Bainbridge SE, Powell RJ, Tighe PJ. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes. Arthritis Rheum 2007;56:2765-73.
21. Abrahams VM, Cambridge G, Lydyard PM, Edwards JC. Induction of tumor necrosis factor α production by adhered human monocytes: a key role for Fey type IIIa in rheumatoid arthritis. Arthritis Rheum 2000;43:608-16.
22. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, et al. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004;50:1457-67.
23. Kramer PR, Kramer SF, Guan G. 17 β-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004;50:1967-75.